Amivantamab, the first epidermal growth factor receptor and mesenchymal–epithelial transition factor inhibitor, associated with penile and inguinal ulcers and paronychia by Karina J. Cancel-Artau, MD, Angélica C. Marrero-Pérez, MD, Eduardo A. Michelén-Gómez, MD, Xavier Sánchez-Flores, MD

Get full text

Acrodermatitis dysmetabolica with concomitant acquired acrodermatitis enteropathica in a patient with maple syrup urine disease by Luis E. Santaliz-Ruiz, IV, MD, Angélica C. Marrero-Pérez, MD, Julio Sánchez-Pont, MD, Oscar Nevárez-Pomales, MD

Get full text